scholarly journals COMPARATIVE STUDY OF CLINICAL EFFICACY AND SIDE EFFECTS OF ADAPALENE 0.1% GEL AND BENZOYL PEROXIDE 2.5% GEL AS MONOTHERAPIES AND COMBINATION THERAPY IN FACIAL ACNE: INDIAN PERSPECTIVE

2014 ◽  
Vol 3 (14) ◽  
pp. 3786-3798
Author(s):  
Adarsh Gowda ◽  
Sanmitha S K ◽  
Satish K S
2020 ◽  
Vol 7 (5) ◽  
pp. 1373
Author(s):  
C. V. Praveen Kumar Reddy ◽  
Surekha A.

Background: The study was done to assess and compare the treatment of keloids with intralesional triamcinolone and combination of 5-fluorouracil and triamcinolone. Despite various options available, there is no universally accepted treatment for keloids. Our objective was to compare two regimens and establish superiority in terms of objective and subjective outcomesMethods: A randomized parallel group study conducted in the Department of Plastic Surgery from January 2017 to June 2019. A total of 80 patients were taken with 40 each group.Results: Though there was improvement in both regimens, this was more significant with combination regimen especially with vascularity, pliability, decrease in height and faster relief of symptoms like pain and itching.Conclusions: Both were effective in treatment of keloids; triamcinolone alone was having relapse rate and combination therapy was more effective with faster results and few side effects. 


2010 ◽  
Vol 16 (1) ◽  
pp. 38 ◽  
Author(s):  
Hong Ryeol Cheong ◽  
Hyun Young Woo ◽  
Jeong Heo ◽  
Ki Tae Yoon ◽  
Dong Uk Kim ◽  
...  

2020 ◽  
Vol 76 (1) ◽  
Author(s):  
Ali Ulas TUGCU ◽  
Figen Sahin ◽  
Gulendam Bozdayi ◽  
Fatma Nur Aksakal ◽  
Gulcin Alp ◽  
...  

2021 ◽  
Vol 13 ◽  
pp. 1759720X2110026
Author(s):  
Chinar R. Parikh ◽  
Jaya K. Ponnampalam ◽  
George Seligmann ◽  
Leda Coelewij ◽  
Ines Pineda-Torra ◽  
...  

The treatment of inflammatory arthritis has been revolutionised by the introduction of biologic treatments. Many biologic agents are currently licensed for use in both paediatric and adult patients with inflammatory arthritis and contribute to improved disease outcomes compared with the pre-biologic era. However, immunogenicity to biologic agents, characterised by an immune reaction leading to the production of anti-drug antibodies (ADAs), can negatively impact the therapeutic efficacy of biologic drugs and induce side effects to treatment. This review explores for the first time the impact of immunogenicity against all licensed biologic treatments currently used in inflammatory arthritis across age, and will examine any significant differences between ADA prevalence, titres and timing of development, as well as ADA impact on therapeutic drug levels, clinical efficacy and side effects between paediatric and adult patients. In addition, we will investigate factors associated with differences in immunogenicity across biologic agents used in inflammatory arthritis, and their potential therapeutic implications.


Sign in / Sign up

Export Citation Format

Share Document